Literature DB >> 27122924

Brain Stem Hemorrhage in a 2-Year-10-Month-Old Child with Renovascular Hypertension Related to Fibromuscular Dysplasia.

Yao-Min Hung1, Ken-Pen Weng2, Chu-Chuan Lin3, Jer-Shyung Huang4, Yee-Hsuan Chiou3, Kai-Sheng Hsieh5.   

Abstract

UNLABELLED: Renovascular hypertension due to fibromuscular dysplasia is an uncommon but important cause of pediatric hypertension. It is usually ignored and diagnosed after a long delay because blood pressure is infrequently measured in children. We report a case of previously undiagnosed renovascular hypertension complicated with right renal infarction in a 2-year-10-month-old child, who initially presented as a case of conscious disturbance. The patient's brain CT displayed brain stem hemorrhage, and a brain MRI showed acute hemorrhage and multiple old intracerebral hemorrhage. Therefore, intimal fibromuscular dysplasia of the right renal artery was diagnosed by computed tomography and confirmed after renal angiography. Her blood pressure was gradually normalized after medical therapy, including use of Losartan. She is presently asymptomatic on OPD follow-up. The importance of BP measurement can not be overemphasized in pediatric patients less than three years of age with underlying diseases. KEY WORDS: Conscious disturbance; Fibromuscular dysplasia; Renovascular hypertension.

Entities:  

Year:  2015        PMID: 27122924      PMCID: PMC4804984          DOI: 10.6515/acs20141027d

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  10 in total

Review 1.  Fibromuscular dysplasia.

Authors:  David P Slovut; Jeffrey W Olin
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Why pediatricians fail to diagnose hypertension: a multicenter survey.

Authors:  Merijn W Bijlsma; Hester N Blufpand; Gertjan J L Kaspers; Arend Bökenkamp
Journal:  J Pediatr       Date:  2013-10-09       Impact factor: 4.406

4.  Reversible renal fibromuscular dysplasia.

Authors:  A A Nemcek; C E Holmburg
Journal:  AJR Am J Roentgenol       Date:  1986-10       Impact factor: 3.959

Review 5.  Diagnosis, management, and future developments of fibromuscular dysplasia.

Authors:  Jeffrey W Olin; Brett A Sealove
Journal:  J Vasc Surg       Date:  2011-01-13       Impact factor: 4.268

6.  Angioplasty for pediatric renovascular hypertension: a 13-year experience.

Authors:  Guangchang Zhu; Fuliang He; Yongquan Gu; Hengxi Yu; Bing Chen; Zhiwei Hu; Weitao Liang; Zhonggao Wang
Journal:  Diagn Interv Radiol       Date:  2014 May-Jun       Impact factor: 2.630

Review 7.  Renovascular hypertension in children.

Authors:  Kjell Tullus; Eileen Brennan; George Hamilton; Rozanne Lord; Clare A McLaren; Stephen D Marks; Derek J Roebuck
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

8.  Pediatric renovascular hypertension: a thirty-year experience of operative treatment.

Authors:  J C Stanley; G B Zelenock; L M Messina; T W Wakefield
Journal:  J Vasc Surg       Date:  1995-02       Impact factor: 4.268

9.  A single pediatric center experience with 1025 children with hypertension.

Authors:  T Wyszyńska; E Cichocka; A Wieteska-Klimczak; K Jobs; P Januszewicz
Journal:  Acta Paediatr       Date:  1992-03       Impact factor: 2.299

10.  Dilation of renal artery stenosis after administration of losartan.

Authors:  Masayuki Tanemoto; Kei Takase; Takayuki Yamada; Akihiro Satoh; Takaaki Abe; Sadayoshi Ito
Journal:  Hypertens Res       Date:  2007-10       Impact factor: 3.872

  10 in total
  1 in total

1.  Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1.

Authors:  Ken Saida; Chong Ae Kim; José Ricardo Magliocco Ceroni; Debora Romeo Bertola; Rachel Sayuri Honjo; Satomi Mitsuhashi; Atsushi Takata; Takeshi Mizuguchi; Satoko Miyatake; Noriko Miyake; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.